Provided by Tiger Trade Technology Pte. Ltd.

Scholar Rock Holding Corp

51.85
-3.5600-6.42%
Post-market: 51.890.0400+0.08%17:58 EDT
Volume:4.04M
Turnover:215.84M
Market Cap:6.31B
PE:-15.43
High:56.90
Open:56.51
Low:51.58
Close:55.41
52wk High:61.76
52wk Low:27.07
Shares:121.79M
Float Shares:107.73M
Volume Ratio:3.23
T/O Rate:3.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3601
EPS(LYR):-3.4845
ROE:-167.77%
ROA:-58.82%
PB:24.88
PE(LYR):-14.88

Loading ...

US FDA - Approves Isembyld for Spinal Muscular Atrophy in Patients Aged 2 Years and Older

THOMSON REUTERS
·
Sep 12

Scholar Rock Holdings trading halted, news pending

TIPRANKS
·
Sep 12

NASDAQ Trade Halt Halt News Pending at 05:07 Pm

Reuters
·
Sep 12

Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 08

Scholar Rock Begins Phase 2 FORGE Trial of Apitegromab in Facioscapulohumeral Muscular Dystrophy

Reuters
·
Sep 02

Scholar Rock Says FDA Grants Fast Track Status for Apitegromab in FSHD

Reuters
·
Sep 02

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (Fshd) Program as Participant Dosing Commences in Phase 2 Forge Trial

THOMSON REUTERS
·
Sep 02

Scholar Rock to Present at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing Pathway - Has The Bull Case Changed?

Simply Wall St.
·
Aug 24

Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says

MT Newswires Live
·
Aug 22

Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating

MT Newswires Live
·
Aug 22

Scholar Rock price target raised to $64 from $58 at Wedbush

TIPRANKS
·
Aug 21

Scholar Rock removes Catalent Indiana from apitegromab BLA under FDA guidance

TIPRANKS
·
Aug 21

Scholar Rock Holding Corporation - Prepared for U.S. Apitegromab Launch upon FDA Approval by Sept 30, 2026 Pdufa Date

THOMSON REUTERS
·
Aug 21

Scholar Rock Holding Corporation - Withdraws Apitegromab Maa in Europe; to Resubmit with Alternate Fill-Finish Facility

THOMSON REUTERS
·
Aug 21

Scholar Rock Holding Corporation - Pmda Agrees no Additional Clinical Studies Required; Scholar Rock to Submit Apitegromab Jnda by Ye 2026

THOMSON REUTERS
·
Aug 21

Scholar Rock Withdraws EU Apitegromab Filing After FDA Flags Catalent Indiana Plant with OAI Inspection Rating

Reuters
·
Aug 21

How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review

Simply Wall St.
·
Aug 15

Scholar Rock Grants Inducement Equity Awards for 51,947 Shares to 12 New Hires

Reuters
·
Aug 15

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 15